←
SotilloLab131 posts
SotilloLab avatar

SotilloLab

@SotilloLab

🔬Join our mouse model-based research lab as we unravel lung and breast cancer's complexity. Discover breakthroughs and shape the future of cancer research!🧬🐁

◷ Joined March 2020▧ 26 Photos and videos
SotilloLab avatar
SotilloLab@SotilloLab·17 Oct 2024

Congratulations to our Master student Eldar, on successfully defending his master’s thesis at our lab. He worked with @MulhamYN on characterizing Eml4-Alk variants using 3D organoids. We wish him all the best in whats coming next!

Post attachmentPost attachment
rocio sotillo avatar
⟳ SotilloLab retweeted
rocio sotillo@rociosotillo·11 Sep 2024

Very excited to attend this meeting!! The 1st animal models of cancer conference last year was incredible and this one 👇will be even better!! Don’t miss the deadline!!

@rociosotillo we're looking forward to your presentation at #AMC25 in the Dominican Republic🇩🇴 next February! Please RT to let your followers know Talk Submission closes next week! ✅Register & Submit: bit.ly/3BbtGoY

Post attachment
Andrea Ventura avatar
⟳ SotilloLab retweeted
Andrea Ventura@aventura71·13 May 2024

An excellent opportunity for graduate students and postdocs to learn about cutting edge cancer research fchampalimaud.org/events/fir…

SotilloLab avatar
SotilloLab@SotilloLab·27 Mar 2024

Overall impact: 💥 This strategy holds significant promise for improved clinical outcomes in ALK-positive lung cancer patients, representing a valuable first-line therapeutic option.

SotilloLab avatar
SotilloLab@SotilloLab·27 Mar 2024

Promising results: 🌟 In vivo 🐁 experiments demonstrated remarkable tumor suppression with the combined ALK and SRC inhibitor treatment without toxicity 👇

SotilloLab avatar
SotilloLab@SotilloLab·27 Mar 2024

Our approach:💡We explored co-targeting ALK and SRC to improve therapeutic efficacy. Extensive (phospho)proteomic analyses revealed a multifaceted cell death mechanism, achieving synergistic mTOR pathway suppression in both ALK-driven murine and patient-derived tumor cells👇

Post attachment
SotilloLab avatar
SotilloLab@SotilloLab·27 Mar 2024

Key takeaway:🔑We identified mechanistically a new therapeutic approach to tackle EML4-ALK-lung cancer. We successfully generated Eml4-Alk variant 1 and 3 tumors in vivo using CRISPR/Cas9🧬, allowing us to investigate combination therapies for enhanced response to ALKinhibitors👇

SotilloLab avatar
SotilloLab@SotilloLab·18 Nov 2023

Very happy to see the latest paper from the Sotillo lab published! A true team effort from @marialbframos, @Alberto_DiazJ, @chocarro_sara, Lena Voith von Voithenberg and others. Special thanks goes to Luca Gasparoli, a fantastic editor at Cell Reports! cell.com/cell-reports/fullte…